Gpx2 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX2 mRNA] | CTD | PMID:31150632 |
Gpx2 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GPX2 mRNA | CTD | PMID:36331819 |
Gpx2 | Rat | (R)-lipoic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of GPX2 mRNA | CTD | PMID:23830814 |
Gpx2 | Rat | (S)-naringenin | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Paraquat co-treated with naringenin] results in increased expression of GPX2 mRNA | CTD | PMID:24561720 |
Gpx2 | Rat | (S)-naringenin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | naringenin results in increased expression of GPX2 mRNA | CTD | PMID:24561720 |
Gpx2 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | EXP | | 6480464 | o and p'-DDT affects the expression of GPX2 mRNA | CTD | PMID:17984292 |
Gpx2 | Rat | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of GPX2 mRNA | CTD | PMID:32387197 |
Gpx2 | Rat | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of GPX2 mRNA | CTD | PMID:32028820 |
Gpx2 | Rat | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with morin] results in increased expression of GPX2 mRNA | CTD | PMID:32028820 |
Gpx2 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of GPX2 mRNA | CTD | PMID:22206623 |
Gpx2 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of GPX2 mRNA] | CTD | PMID:22206623 |
Gpx2 | Rat | 1-chloro-2,4-dinitrobenzene | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Dinitrochlorobenzene affects the expression of GPX2 mRNA | CTD | PMID:28219650 |
Gpx2 | Rat | 1-chloro-2,4-dinitrobenzene | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of GPX2 mRNA] | CTD | PMID:28219650 |
Gpx2 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GPX2 mRNA more ... | CTD | PMID:30517764 and PMID:33749747 |
Gpx2 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA | CTD | PMID:30723492 |
Gpx2 | Rat | 1-naphthyl isothiocyanate | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA | CTD | PMID:30517764 and PMID:33749747 |
Gpx2 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPX2 mRNA | CTD | PMID:17942748 |
Gpx2 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of GPX2 mRNA | CTD | PMID:15576828 more ... |
Gpx2 | Rat | 17beta-estradiol | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA more ... | CTD | PMID:17404688 more ... |
Gpx2 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA | CTD | PMID:32741896 |
Gpx2 | Rat | 17beta-estradiol | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of GPX2 mRNA | CTD | PMID:19619570 and PMID:21185374 |
Gpx2 | Rat | 17beta-estradiol | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of GPX2 mRNA | CTD | PMID:20106945 |
Gpx2 | Rat | 17beta-estradiol 3-benzoate | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA | CTD | PMID:32741896 |
Gpx2 | Rat | 1H-pyrazole | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | pyrazole results in increased expression of GPX2 mRNA | CTD | PMID:17945193 |
Gpx2 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:20005886 and PMID:21851831 |
Gpx2 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [2 more ... | CTD | PMID:21851831 |
Gpx2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA and [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA | CTD | PMID:19619570 and PMID:26159488 |
Gpx2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPX2 mRNA | CTD | PMID:28213091 |
Gpx2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPX2 mRNA | CTD | PMID:21570461 and PMID:26377647 |
Gpx2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GPX2 mRNA | CTD | PMID:21215274 |
Gpx2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GPX2 mRNA | CTD | PMID:19619570 |
Gpx2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GPX2 mRNA more ... | CTD | PMID:17942748 and PMID:21851831 |
Gpx2 | Rat | 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of GPX2 mRNA | CTD | PMID:31669340 |
Gpx2 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
Gpx2 | Rat | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA and [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GPX2 mRNA | CTD | PMID:14656948 and PMID:16158176 |
Gpx2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:34256052 |
Gpx2 | Rat | 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | AHR gene mutant form inhibits the reaction [3 more ... | CTD | PMID:34256052 |
Gpx2 | Rat | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in increased expression of GPX2 mRNA | CTD | PMID:31326446 |
Gpx2 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GPX2 mRNA | CTD | PMID:20188158 |
Gpx2 | Rat | 3,7-dihydropurine-6-thione | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Mercaptopurine results in increased expression of GPX2 mRNA | CTD | PMID:18222062 |
Gpx2 | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [cinnamaldehyde results in increased expression of GPX2 mRNA] | CTD | PMID:28219650 |
Gpx2 | Rat | 3-phenylprop-2-enal | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | cinnamaldehyde affects the expression of GPX2 mRNA | CTD | PMID:28219650 |
Gpx2 | Rat | 3-phenylprop-2-enal | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | cinnamaldehyde results in increased expression of GPX2 mRNA | CTD | PMID:19000754 |
Gpx2 | Rat | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of GPX2 mRNA | CTD | PMID:19162173 |
Gpx2 | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of GPX2 mRNA | CTD | PMID:30723492 |
Gpx2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of GPX2 mRNA | CTD | PMID:30951980 |
Gpx2 | Rat | 4-hydroxy-TEMPO | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [tempol co-treated with Tobacco Smoke Pollution] results in increased expression of GPX2 mRNA and tempol promotes the reaction [Tobacco Smoke Pollution results in increased expression of GPX2 protein] | CTD | PMID:32726580 |
Gpx2 | Rat | 4-hydroxynon-2-enal | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of GPX2 mRNA | CTD | PMID:12419474 |
Gpx2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Fenretinide results in increased expression of GPX2 mRNA | CTD | PMID:15623509 |
Gpx2 | Rat | 4-nitroquinoline N-oxide | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] | CTD | PMID:32942007 |
Gpx2 | Rat | 5-fluorouracil | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of GPX2 mRNA] | CTD | PMID:15016801 |
Gpx2 | Rat | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | multiple interactions | EXP | | 6480464 | [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA | CTD | PMID:22687989 |
Gpx2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of GPX2 mRNA | CTD | PMID:24780913 |
Gpx2 | Rat | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:18056462 |
Gpx2 | Rat | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Uric Acid] results in increased expression of GPX2 mRNA | CTD | PMID:33749747 |
Gpx2 | Rat | 9-cis-retinoic acid | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Alitretinoin results in increased expression of GPX2 mRNA | CTD | PMID:15623509 |
Gpx2 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GPX2 mRNA | CTD | PMID:31881176 |
Gpx2 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of GPX2 mRNA | CTD | PMID:28959563 |
Gpx2 | Rat | aflatoxin B1 | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of GPX2 protein | CTD | PMID:20106945 |
Gpx2 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GPX2 mRNA | CTD | PMID:23385219 more ... |
Gpx2 | Rat | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of GPX2 mRNA | CTD | PMID:28027979 |
Gpx2 | Rat | aldehydo-D-glucose | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] | CTD | PMID:32942007 |
Gpx2 | Rat | all-trans-retinoic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in increased expression of GPX2 mRNA | CTD | PMID:16443354 |
Gpx2 | Rat | all-trans-retinoic acid | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GPX2 mRNA | CTD | PMID:10498757 and PMID:17045167 |
Gpx2 | Rat | all-trans-retinoic acid | increases activity | ISO | GPX2 (Homo sapiens) | 6480464 | Tretinoin results in increased activity of GPX2 protein | CTD | PMID:10498757 |
Gpx2 | Rat | allopurinol | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Allopurinol] results in increased expression of GPX2 mRNA | CTD | PMID:33749747 |
Gpx2 | Rat | alpha-hexachlorocyclohexane | increases expression | EXP | | 6480464 | alpha-hexachlorocyclohexane results in increased expression of GPX2 mRNA | CTD | PMID:17785943 |
Gpx2 | Rat | antimonite | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA | CTD | PMID:32076005 |
Gpx2 | Rat | aristolochic acid A | multiple interactions | EXP | | 6480464 | [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of GPX2 mRNA | CTD | PMID:23912714 |
Gpx2 | Rat | arotinoid acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gpx2 | Rat | arsane | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Arsenic results in increased expression of GPX2 mRNA | CTD | PMID:19945496 |
Gpx2 | Rat | arsane | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Arsenic] results in increased expression of GPX2 mRNA and [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPX2 mRNA | CTD | PMID:32525701 and PMID:36861143 |
Gpx2 | Rat | arsenic acid | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | arsenic acid results in decreased expression of GPX2 mRNA | CTD | PMID:19429247 |
Gpx2 | Rat | arsenic atom | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Arsenic results in increased expression of GPX2 mRNA | CTD | PMID:19945496 |
Gpx2 | Rat | arsenic atom | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Arsenic] results in increased expression of GPX2 mRNA and [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPX2 mRNA | CTD | PMID:32525701 and PMID:36861143 |
Gpx2 | Rat | arsenite(3-) | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | arsenite results in decreased expression of GPX2 mRNA | CTD | PMID:19429247 and PMID:33053406 |
Gpx2 | Rat | arsenite(3-) | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GPX2 mRNA | CTD | PMID:32076005 |
Gpx2 | Rat | atazanavir sulfate | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of GPX2 mRNA | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | atazanavir sulfate | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Atazanavir Sulfate results in decreased expression of GPX2 mRNA | CTD | PMID:32152650 |
Gpx2 | Rat | atrazine | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of GPX2 mRNA] | CTD | PMID:36216167 |
Gpx2 | Rat | atrazine | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Atrazine results in increased expression of GPX2 mRNA | CTD | PMID:36216167 |
Gpx2 | Rat | Augmentin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA | CTD | PMID:34767876 |
Gpx2 | Rat | azathioprine | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Azathioprine results in increased expression of GPX2 mRNA | CTD | PMID:18222062 |
Gpx2 | Rat | Bardoxolone methyl | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | bardoxolone methyl affects the expression of GPX2 mRNA | CTD | PMID:34480604 |
Gpx2 | Rat | benzalkonium chloride | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Benzalkonium Compounds results in increased expression of GPX2 mRNA | CTD | PMID:30171875 |
Gpx2 | Rat | benzo[a]pyrene | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GPX2 mRNA | CTD | PMID:15735009 |
Gpx2 | Rat | benzo[a]pyrene | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of GPX2 mRNA | CTD | PMID:32234424 |
Gpx2 | Rat | benzo[a]pyrene | decreases methylation | ISO | GPX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of GPX2 promoter | CTD | PMID:27901495 |
Gpx2 | Rat | benzo[a]pyrene | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GPX2 mRNA | CTD | PMID:25908611 |
Gpx2 | Rat | benzo[a]pyrene | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of GPX2 mRNA | CTD | PMID:22228805 |
Gpx2 | Rat | benzo[a]pyrene | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene inhibits the reaction [glucoraphanin results in increased expression of GPX2 mRNA] | CTD | PMID:20868228 |
Gpx2 | Rat | beta-naphthoflavone | increases expression | EXP | | 6480464 | beta-Naphthoflavone results in increased expression of GPX2 mRNA and beta-Naphthoflavone results in increased expression of GPX2 protein | CTD | PMID:19389873 more ... |
Gpx2 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPX2 mRNA | CTD | PMID:18164116 and PMID:20045035 |
Gpx2 | Rat | bifenthrin | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | bifenthrin results in increased expression of GPX2 mRNA | CTD | PMID:26071804 |
Gpx2 | Rat | bifenthrin | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | bifenthrin results in decreased expression of GPX2 mRNA | CTD | PMID:27916261 |
Gpx2 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Mustard Gas results in increased expression of GPX2 mRNA | CTD | PMID:25102026 |
Gpx2 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of GPX2 mRNA | CTD | PMID:25181051 |
Gpx2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GPX2 mRNA | CTD | PMID:36779543 |
Gpx2 | Rat | bisphenol A | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GPX2 mRNA | CTD | PMID:34585602 |
Gpx2 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of GPX2 mRNA] | CTD | PMID:34067838 |
Gpx2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPX2 mRNA | CTD | PMID:34067838 and PMID:34947998 |
Gpx2 | Rat | bisphenol A | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of GPX2 mRNA | CTD | PMID:30903817 |
Gpx2 | Rat | bisphenol A | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GPX2 mRNA | CTD | PMID:30951980 |
Gpx2 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of GPX2 gene | CTD | PMID:28505145 |
Gpx2 | Rat | bisphenol F | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | bisphenol F affects the expression of GPX2 mRNA | CTD | PMID:30951980 |
Gpx2 | Rat | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of GPX2 mRNA | CTD | PMID:17538237 |
Gpx2 | Rat | buta-1,3-diene | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of GPX2 mRNA | CTD | PMID:29038090 |
Gpx2 | Rat | butanal | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of GPX2 mRNA | CTD | PMID:26079696 |
Gpx2 | Rat | cadmium atom | affects activity | EXP | | 6480464 | Cadmium affects the activity of GPX2 protein | CTD | PMID:16865233 |
Gpx2 | Rat | cadmium atom | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Cadmium results in increased expression of GPX2 mRNA | CTD | PMID:26363317 |
Gpx2 | Rat | cadmium dichloride | affects activity | EXP | | 6480464 | Cadmium Chloride affects the activity of GPX2 protein | CTD | PMID:16865233 |
Gpx2 | Rat | cadmium dichloride | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of GPX2 mRNA | CTD | PMID:22677785 more ... |
Gpx2 | Rat | cadmium dichloride | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Cadmium Chloride affects the expression of GPX2 mRNA | CTD | PMID:18974090 |
Gpx2 | Rat | cadmium sulfate | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPX2 mRNA | CTD | PMID:18654764 |
Gpx2 | Rat | calcitriol | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of GPX2 mRNA | CTD | PMID:21592394 |
Gpx2 | Rat | calcitriol | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GPX2 mRNA | CTD | PMID:21592394 |
Gpx2 | Rat | cannabidiol | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of GPX2 mRNA | CTD | PMID:31518892 |
Gpx2 | Rat | carbamazepine | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GPX2 mRNA | CTD | PMID:24752500 |
Gpx2 | Rat | carbamazepine | multiple interactions | EXP | | 6480464 | [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in increased expression of GPX2 mRNA more ... | CTD | PMID:35786680 |
Gpx2 | Rat | cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of GPX2 mRNA | CTD | PMID:18500788 |
Gpx2 | Rat | ceric oxide | decreases expression | EXP | | 6480464 | ceric oxide results in decreased expression of GPX2 mRNA | CTD | PMID:29463257 |
Gpx2 | Rat | cerium trichloride | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | cerous chloride results in decreased expression of GPX2 mRNA | CTD | PMID:28954213 |
Gpx2 | Rat | CGP 52608 | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GPX2 gene] | CTD | PMID:28238834 |
Gpx2 | Rat | chenodeoxycholic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | CHIR 99021 | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gpx2 | Rat | chloroprene | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Chloroprene results in increased expression of GPX2 mRNA | CTD | PMID:23125180 |
Gpx2 | Rat | chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of GPX2 mRNA | CTD | PMID:19440498 |
Gpx2 | Rat | chlorpyrifos | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of GPX2 mRNA | CTD | PMID:32602772 |
Gpx2 | Rat | cholesterol | multiple interactions | EXP | | 6480464 | [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of GPX2 mRNA | CTD | PMID:26606054 |
Gpx2 | Rat | choline | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPX2 mRNA | CTD | PMID:20938992 |
Gpx2 | Rat | chromium(6+) | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Arsenates co-treated with chromium hexavalent ion] results in increased expression of GPX2 mRNA | CTD | PMID:19895865 |
Gpx2 | Rat | cisplatin | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Cisplatin results in increased expression of GPX2 mRNA | CTD | PMID:24865317 |
Gpx2 | Rat | cisplatin | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of GPX2 mRNA | CTD | PMID:27392435 |
Gpx2 | Rat | cisplatin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GPX2 mRNA | CTD | PMID:27392435 |
Gpx2 | Rat | cisplatin | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Lutein co-treated with Cisplatin] results in increased expression of GPX2 mRNA | CTD | PMID:24865317 |
Gpx2 | Rat | clavulanic acid | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Clavulanic Acid results in increased expression of GPX2 mRNA | CTD | PMID:34767876 |
Gpx2 | Rat | cobalt atom | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Cobalt co-treated with Organometallic Compounds] results in increased expression of GPX2 mRNA | CTD | PMID:22147119 |
Gpx2 | Rat | cobalt atom | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Cobalt results in increased expression of GPX2 mRNA | CTD | PMID:22147119 |
Gpx2 | Rat | cobalt dichloride | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPX2 mRNA | CTD | PMID:18654764 |
Gpx2 | Rat | cobalt dichloride | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of GPX2 mRNA | CTD | PMID:19376846 |
Gpx2 | Rat | cobicistat | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Rifampin co-treated with Cobicistat] results in increased expression of GPX2 mRNA | CTD | PMID:33629115 |
Gpx2 | Rat | copper atom | decreases expression | EXP | | 6480464 | Copper deficiency results in decreased expression of GPX2 mRNA and Copper results in decreased expression of GPX2 mRNA | CTD | PMID:19497425 and PMID:30556269 |
Gpx2 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of GPX2 mRNA | CTD | PMID:22465980 |
Gpx2 | Rat | copper(0) | decreases expression | EXP | | 6480464 | Copper deficiency results in decreased expression of GPX2 mRNA and Copper results in decreased expression of GPX2 mRNA | CTD | PMID:19497425 and PMID:30556269 |
Gpx2 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of GPX2 mRNA | CTD | PMID:22465980 |
Gpx2 | Rat | cortisol | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gpx2 | Rat | CU-O LINKAGE | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of GPX2 mRNA | CTD | PMID:32285662 |
Gpx2 | Rat | cumene hydroperoxide | increases reduction | ISO | GPX2 (Homo sapiens) | 6480464 | GPX2 protein results in increased reduction of cumene hydroperoxide | CTD | PMID:8428933 |
Gpx2 | Rat | cyclosporin A | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GPX2 mRNA | CTD | PMID:20106945 more ... |
Gpx2 | Rat | cyclosporin A | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of GPX2 mRNA | CTD | PMID:33819548 |
Gpx2 | Rat | cyfluthrin | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | cyfluthrin results in decreased expression of GPX2 mRNA | CTD | PMID:31330490 |
Gpx2 | Rat | cylindrospermopsin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of GPX2 mRNA | CTD | PMID:24921660 |
Gpx2 | Rat | cypermethrin | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | cypermethrin results in increased expression of GPX2 mRNA | CTD | PMID:21397294 |
Gpx2 | Rat | cyproconazole | decreases expression | EXP | | 6480464 | cyproconazole results in decreased expression of GPX2 mRNA | CTD | PMID:25182419 |
Gpx2 | Rat | cyproconazole | multiple interactions | EXP | | 6480464 | [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA | CTD | PMID:29038839 |
Gpx2 | Rat | cyproconazole | increases expression | EXP | | 6480464 | cyproconazole results in increased expression of GPX2 mRNA | CTD | PMID:29038839 |
Gpx2 | Rat | D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of GPX2 mRNA | CTD | PMID:28027979 |
Gpx2 | Rat | D-glucose | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] | CTD | PMID:32942007 |
Gpx2 | Rat | deoxycholic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | dextran sulfate | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GPX2 protein] | CTD | PMID:35362542 |
Gpx2 | Rat | dextran sulfate | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of GPX2 protein | CTD | PMID:35362542 |
Gpx2 | Rat | diazinon | affects expression | EXP | | 6480464 | Diazinon affects the expression of GPX2 mRNA | CTD | PMID:17452286 and PMID:19440498 |
Gpx2 | Rat | diazinon | increases expression | EXP | | 6480464 | Diazinon results in increased expression of GPX2 mRNA | CTD | PMID:19440498 |
Gpx2 | Rat | Dibutyl phosphate | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of GPX2 mRNA | CTD | PMID:37042841 |
Gpx2 | Rat | diclofenac | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | Diclofenac affects the expression of GPX2 mRNA | CTD | PMID:24752500 |
Gpx2 | Rat | dicyclanil | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA and Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of GPX2 mRNA] | CTD | PMID:19182440 |
Gpx2 | Rat | diethyl maleate | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | diethyl maleate affects the expression of GPX2 mRNA | CTD | PMID:34480604 |
Gpx2 | Rat | dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of GPX2 mRNA | CTD | PMID:37567419 |
Gpx2 | Rat | dioxygen | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of GPX2 mRNA | CTD | PMID:35883890 |
Gpx2 | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA | CTD | PMID:32076005 |
Gpx2 | Rat | diquat | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Diquat results in decreased expression of GPX2 mRNA | CTD | PMID:36572071 |
Gpx2 | Rat | diquat | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [3 and 4-dihydroxyphenylethanol co-treated with Diquat] results in decreased expression of GPX2 mRNA | CTD | PMID:36572071 |
Gpx2 | Rat | disodium selenite | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Sodium Selenite results in increased expression of GPX2 protein | CTD | PMID:25187657 |
Gpx2 | Rat | doramapimod | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | doramapimod results in increased expression of GPX2 mRNA | CTD | PMID:21328587 |
Gpx2 | Rat | elemental selenium | decreases activity | ISO | Gpx2 (Mus musculus) | 6480464 | Selenium deficiency results in decreased activity of GPX2 protein | CTD | PMID:15795427 |
Gpx2 | Rat | elemental selenium | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Selenium deficiency results in decreased expression of GPX2 mRNA | CTD | PMID:15795427 |
Gpx2 | Rat | emodin | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of GPX2 mRNA] | CTD | PMID:30517764 |
Gpx2 | Rat | endosulfan | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of GPX2 mRNA | CTD | PMID:26159488 |
Gpx2 | Rat | endosulfan | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Endosulfan results in increased expression of GPX2 mRNA | CTD | PMID:26159488 |
Gpx2 | Rat | enilconazole | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | enilconazole results in decreased expression of GPX2 mRNA | CTD | PMID:29451352 |
Gpx2 | Rat | epoxiconazole | multiple interactions | EXP | | 6480464 | [cyproconazole co-treated with epoxiconazole] results in increased expression of GPX2 mRNA | CTD | PMID:29038839 |
Gpx2 | Rat | erythromycin estolate | increases expression | EXP | | 6480464 | Erythromycin Estolate results in increased expression of GPX2 mRNA | CTD | PMID:24412560 |
Gpx2 | Rat | ethanol | multiple interactions | EXP | | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of GPX2 mRNA | CTD | PMID:17347304 |
Gpx2 | Rat | Evodiamine | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GPX2 protein] | CTD | PMID:35362542 |
Gpx2 | Rat | fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA | CTD | PMID:18253720 and PMID:18775883 |
Gpx2 | Rat | fenofibrate | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Fenofibrate inhibits the reaction [triptolide results in increased expression of GPX2 mRNA] | CTD | PMID:31241159 |
Gpx2 | Rat | fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of GPX2 mRNA | CTD | PMID:17264098 and PMID:18775883 |
Gpx2 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of GPX2 mRNA | CTD | PMID:21203749 and PMID:24136188 |
Gpx2 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of GPX2 mRNA | CTD | PMID:24793618 |
Gpx2 | Rat | folic acid | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPX2 mRNA more ... | CTD | PMID:20938992 and PMID:22206623 |
Gpx2 | Rat | folic acid | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of GPX2 mRNA | CTD | PMID:25629700 |
Gpx2 | Rat | folpet | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | folpet results in increased expression of GPX2 mRNA | CTD | PMID:31558096 |
Gpx2 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of GPX2 mRNA | CTD | PMID:25539665 more ... |
Gpx2 | Rat | genistein | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Genistein results in decreased expression of GPX2 mRNA | CTD | PMID:32186404 |
Gpx2 | Rat | glucobrassicin | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | glucobrassicin analog inhibits the reaction [glucoraphanin analog results in increased expression of GPX2 mRNA] | CTD | PMID:20868228 |
Gpx2 | Rat | glucobrassicin | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | glucobrassicin analog results in decreased expression of GPX2 protein | CTD | PMID:20868228 |
Gpx2 | Rat | glucoraphanin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | glucoraphanin analog results in increased expression of GPX2 mRNA and glucoraphanin analog results in increased expression of GPX2 protein | CTD | PMID:20868228 |
Gpx2 | Rat | glucoraphanin | increases expression | EXP | | 152998882 | Glucoraphanin increases expression of Gpx2 mRNA in the jejunum | RGD | |
Gpx2 | Rat | glucoraphanin | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | Benzo(a)pyrene inhibits the reaction [glucoraphanin results in increased expression of GPX2 mRNA] and glucobrassicin analog inhibits the reaction [glucoraphanin analog results in increased expression of GPX2 mRNA] | CTD | PMID:20868228 |
Gpx2 | Rat | glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of GPX2 mRNA | CTD | PMID:28027979 |
Gpx2 | Rat | glucose | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | Glucose inhibits the reaction [4-Nitroquinoline-1-oxide results in increased expression of GPX2 protein] | CTD | PMID:32942007 |
Gpx2 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | glycocholic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | glycodeoxycholic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | glycyrrhetinate | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] | CTD | PMID:23341968 |
Gpx2 | Rat | glycyrrhetinic acid | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] | CTD | PMID:23341968 |
Gpx2 | Rat | gold atom | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Gold analog results in increased expression of GPX2 mRNA and Gold results in increased expression of GPX2 mRNA | CTD | PMID:25523186 and PMID:36057382 |
Gpx2 | Rat | gold(0) | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Gold analog results in increased expression of GPX2 mRNA and Gold results in increased expression of GPX2 mRNA | CTD | PMID:25523186 and PMID:36057382 |
Gpx2 | Rat | hexadecanoic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of GPX2 mRNA | CTD | PMID:28027979 |
Gpx2 | Rat | hydrogen peroxide | increases reduction | ISO | GPX2 (Homo sapiens) | 6480464 | GPX2 protein results in increased reduction of Hydrogen Peroxide | CTD | PMID:8428933 |
Gpx2 | Rat | hydrogen peroxide | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of GPX2 mRNA | CTD | PMID:12414654 |
Gpx2 | Rat | hydrogen peroxide | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of GPX2 mRNA | CTD | PMID:20044591 |
Gpx2 | Rat | hydroquinone | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of GPX2 mRNA | CTD | PMID:31256213 |
Gpx2 | Rat | hydroxytyrosol | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [3 and 4-dihydroxyphenylethanol co-treated with Diquat] results in decreased expression of GPX2 mRNA | CTD | PMID:36572071 |
Gpx2 | Rat | hydroxytyrosol | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | 3 and 4-dihydroxyphenylethanol results in decreased expression of GPX2 mRNA | CTD | PMID:36572071 |
Gpx2 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of GPX2 mRNA | CTD | PMID:21396975 |
Gpx2 | Rat | indole-3-methanol | increases expression | EXP | | 6480464 | indole-3-carbinol results in increased expression of GPX2 mRNA | CTD | PMID:21203749 and PMID:24418717 |
Gpx2 | Rat | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA more ... | CTD | PMID:22129741 and PMID:24418717 |
Gpx2 | Rat | iron atom | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of GPX2 mRNA | CTD | PMID:16629162 |
Gpx2 | Rat | iron atom | affects expression | EXP | | 6480464 | Iron affects the expression of GPX2 mRNA | CTD | PMID:24388910 |
Gpx2 | Rat | iron(0) | increases expression | EXP | | 6480464 | Iron deficiency results in increased expression of GPX2 mRNA | CTD | PMID:16629162 |
Gpx2 | Rat | iron(0) | affects expression | EXP | | 6480464 | Iron affects the expression of GPX2 mRNA | CTD | PMID:24388910 |
Gpx2 | Rat | isotretinoin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Isotretinoin results in increased expression of GPX2 mRNA | CTD | PMID:15623509 |
Gpx2 | Rat | L-ascorbic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mRNA more ... | CTD | PMID:16443354 more ... |
Gpx2 | Rat | L-ascorbic acid 2-phosphate | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of GPX2 mRNA | CTD | PMID:34480604 |
Gpx2 | Rat | L-methionine | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPX2 mRNA | CTD | PMID:20938992 |
Gpx2 | Rat | lead(II) chloride | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPX2 mRNA | CTD | PMID:18654764 |
Gpx2 | Rat | lead(II) chloride | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | lead chloride results in increased expression of GPX2 mRNA | CTD | PMID:23503628 |
Gpx2 | Rat | linoleic acid hydroperoxide | increases reduction | ISO | GPX2 (Homo sapiens) | 6480464 | GPX2 protein results in increased reduction of linoleic acid hydroperoxide | CTD | PMID:8428933 |
Gpx2 | Rat | lipoic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of GPX2 mRNA | CTD | PMID:23830814 |
Gpx2 | Rat | lipopolysaccharide | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | 3 and 4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of GPX2 mRNA] | CTD | PMID:25843059 |
Gpx2 | Rat | lipopolysaccharide | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of GPX2 mRNA | CTD | PMID:25843059 |
Gpx2 | Rat | lutein | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Lutein co-treated with Cisplatin] results in increased expression of GPX2 mRNA | CTD | PMID:24865317 |
Gpx2 | Rat | lycopene | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of GPX2 mRNA] | CTD | PMID:36216167 |
Gpx2 | Rat | melatonin | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of GPX2 mRNA | CTD | PMID:20033131 |
Gpx2 | Rat | menadione | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of GPX2 mRNA | CTD | PMID:12414654 |
Gpx2 | Rat | mercaptopurine | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Mercaptopurine results in increased expression of GPX2 mRNA | CTD | PMID:18222062 |
Gpx2 | Rat | methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of GPX2 mRNA | CTD | PMID:25242409 |
Gpx2 | Rat | methotrexate | affects response to substance | ISO | GPX2 (Homo sapiens) | 6480464 | GPX2 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 |
Gpx2 | Rat | methylmercury chloride | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GPX2 mRNA | CTD | PMID:28001369 |
Gpx2 | Rat | microcystin-LR | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of GPX2 mRNA | CTD | PMID:17654400 |
Gpx2 | Rat | microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of GPX2 mRNA | CTD | PMID:34740672 |
Gpx2 | Rat | Mitotane | increases expression | EXP | | 6480464 | Mitotane analog results in increased expression of GPX2 mRNA and Mitotane results in increased expression of GPX2 mRNA | CTD | PMID:23485034 |
Gpx2 | Rat | monocrotaline | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA | CTD | PMID:21224054 |
Gpx2 | Rat | monosodium L-glutamate | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Sodium Glutamate affects the expression of GPX2 mRNA | CTD | PMID:25473020 |
Gpx2 | Rat | monosodium L-glutamate | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Sodium Glutamate results in decreased expression of GPX2 protein | CTD | PMID:25473020 |
Gpx2 | Rat | morin | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with morin] results in increased expression of GPX2 mRNA | CTD | PMID:32028820 |
Gpx2 | Rat | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA] | CTD | PMID:22129741 |
Gpx2 | Rat | N-methyl-N-nitrosourea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of GPX2 mRNA and Methylnitrosourea results in increased expression of GPX2 protein | CTD | PMID:18056462 |
Gpx2 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA and Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with dicyclanil] results in increased expression of GPX2 mRNA] | CTD | PMID:19182440 |
Gpx2 | Rat | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of GPX2 mRNA | CTD | PMID:19638242 and PMID:25242409 |
Gpx2 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA more ... | CTD | PMID:14656948 more ... |
Gpx2 | Rat | N-nitrosomorpholine | increases expression | EXP | | 6480464 | N-nitrosomorpholine results in increased expression of GPX2 mRNA | CTD | PMID:19716841 |
Gpx2 | Rat | nefazodone | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of GPX2 mRNA and [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GPX2 mRNA | CTD | PMID:32152650 and PMID:33819548 |
Gpx2 | Rat | nefazodone | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | nefazodone results in decreased expression of GPX2 mRNA | CTD | PMID:32152650 |
Gpx2 | Rat | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of GPX2 mRNA | CTD | PMID:19440498 |
Gpx2 | Rat | nickel atom | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Nickel results in increased expression of GPX2 mRNA | CTD | PMID:25583101 |
Gpx2 | Rat | nitric oxide | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Nitric Oxide deficiency results in increased expression of GPX2 mRNA | CTD | PMID:15878706 |
Gpx2 | Rat | obeticholic acid | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | obeticholic acid results in decreased expression of GPX2 mRNA | CTD | PMID:27939613 |
Gpx2 | Rat | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of GPX2 mRNA | CTD | PMID:24120684 |
Gpx2 | Rat | omeprazole | multiple interactions | EXP | | 6480464 | [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA | CTD | PMID:22687989 |
Gpx2 | Rat | orphenadrine | multiple interactions | EXP | | 6480464 | [Orphenadrine co-treated with Diethylnitrosamine] results in increased expression of GPX2 mRNA and [Phenobarbital co-treated with Orphenadrine] affects the expression of GPX2 mRNA | CTD | PMID:23665939 and PMID:23665940 |
Gpx2 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of GPX2 mRNA | CTD | PMID:23665939 and PMID:23665940 |
Gpx2 | Rat | oxfendazole | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA more ... | CTD | PMID:18754104 and PMID:20033131 |
Gpx2 | Rat | ozone | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Ozone results in increased expression of GPX2 mRNA | CTD | PMID:17095637 and PMID:23766849 |
Gpx2 | Rat | ozone | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Ozone results in increased expression of GPX2 mRNA] | CTD | PMID:23766849 |
Gpx2 | Rat | p-toluidine | increases expression | EXP | | 6480464 | 4-toluidine results in increased expression of GPX2 mRNA | CTD | PMID:27638505 |
Gpx2 | Rat | paclitaxel | multiple interactions | EXP | | 6480464 | parthenolide inhibits the reaction [Paclitaxel results in decreased expression of GPX2 mRNA] | CTD | PMID:37949423 |
Gpx2 | Rat | paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of GPX2 mRNA | CTD | PMID:37949423 |
Gpx2 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GPX2 mRNA | CTD | PMID:25242409 |
Gpx2 | Rat | paracetamol | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of GPX2 mRNA | CTD | PMID:34390818 |
Gpx2 | Rat | paracetamol | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [CAT protein affects the susceptibility to Acetaminophen] which affects the expression of GPX2 mRNA | CTD | PMID:34390818 |
Gpx2 | Rat | paracetamol | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of GPX2 mRNA | CTD | PMID:33819548 |
Gpx2 | Rat | paracetamol | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GPX2 mRNA | CTD | PMID:22230336 |
Gpx2 | Rat | paracetamol | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GPX2 mRNA | CTD | PMID:21420995 and PMID:29067470 |
Gpx2 | Rat | paraquat | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Paraquat results in increased expression of GPX2 mRNA | CTD | PMID:10806356 |
Gpx2 | Rat | paraquat | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Paraquat co-treated with naringenin] results in increased expression of GPX2 mRNA | CTD | PMID:24561720 |
Gpx2 | Rat | paraquat | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of GPX2 mRNA | CTD | PMID:21688324 |
Gpx2 | Rat | paraquat | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | APOD protein affects the reaction [Paraquat results in decreased expression of GPX2 mRNA] | CTD | PMID:21688324 |
Gpx2 | Rat | paraquat | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Paraquat affects the expression of GPX2 mRNA | CTD | PMID:12732627 |
Gpx2 | Rat | parthenolide | multiple interactions | EXP | | 6480464 | parthenolide inhibits the reaction [Paclitaxel results in decreased expression of GPX2 mRNA] | CTD | PMID:37949423 |
Gpx2 | Rat | pentane-2,3-dione | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | 2 and 3-pentanedione results in increased expression of GPX2 mRNA | CTD | PMID:30710127 |
Gpx2 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of GPX2 mRNA | CTD | PMID:19162173 |
Gpx2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GPX2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GPX2 mRNA | CTD | PMID:36331819 |
Gpx2 | Rat | perfluorooctanoic acid | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [perfluorooctanoic acid co-treated with Dietary Fats more ... | CTD | PMID:20118188 and PMID:23626681 |
Gpx2 | Rat | perfluorooctanoic acid | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of GPX2 mRNA | CTD | PMID:37302725 |
Gpx2 | Rat | perfluorooctanoic acid | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of GPX2 mRNA | CTD | PMID:20118188 |
Gpx2 | Rat | phenobarbital | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GPX2 mRNA] | CTD | PMID:19482888 |
Gpx2 | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GPX2 mRNA | CTD | PMID:24418717 |
Gpx2 | Rat | phenobarbital | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Phenobarbital] results in increased expression of GPX2 mRNA more ... | CTD | PMID:23665940 more ... |
Gpx2 | Rat | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of GPX2 mRNA | CTD | PMID:23665940 and PMID:24025784 |
Gpx2 | Rat | phenobarbital | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of GPX2 mRNA | CTD | PMID:19482888 |
Gpx2 | Rat | phenytoin | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA | CTD | PMID:21224054 |
Gpx2 | Rat | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 more ... | CTD | PMID:18056462 |
Gpx2 | Rat | phosgene | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Phosgene affects the expression of GPX2 mRNA | CTD | PMID:16300373 |
Gpx2 | Rat | phoxim | multiple interactions | EXP | | 6480464 | Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA] | CTD | PMID:30003487 |
Gpx2 | Rat | phoxim | increases expression | EXP | | 6480464 | phoxim results in increased expression of GPX2 mRNA | CTD | PMID:30003487 |
Gpx2 | Rat | piperonyl butoxide | multiple interactions | EXP | | 6480464 | Piperonyl Butoxide affects the reaction [Phenobarbital affects the expression of GPX2 mRNA] and Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of GPX2 mRNA] | CTD | PMID:18544911 and PMID:24025784 |
Gpx2 | Rat | piperonyl butoxide | affects expression | EXP | | 6480464 | Piperonyl Butoxide affects the expression of GPX2 mRNA | CTD | PMID:24025784 |
Gpx2 | Rat | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GPX2 mRNA | CTD | PMID:17498859 more ... |
Gpx2 | Rat | pirinixic acid | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPX2 mRNA | CTD | PMID:19710929 |
Gpx2 | Rat | pirinixic acid | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GPX2 mRNA | CTD | PMID:17426115 |
Gpx2 | Rat | pirinixic acid | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of GPX2 mRNA | CTD | PMID:16985257 |
Gpx2 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of GPX2 mRNA | CTD | PMID:19162173 |
Gpx2 | Rat | progesterone | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of GPX2 mRNA | CTD | PMID:17404688 |
Gpx2 | Rat | progesterone | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | Progesterone affects the expression of GPX2 mRNA | CTD | PMID:17251523 |
Gpx2 | Rat | progesterone | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Progesterone results in decreased expression of GPX2 mRNA | CTD | PMID:17404688 |
Gpx2 | Rat | propanal | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of GPX2 mRNA | CTD | PMID:26079696 |
Gpx2 | Rat | prostaglandin E2 | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [GPX2 protein affects the activity of PTGS2 protein] which affects the metabolism of Dinoprostone and [GPX2 protein affects the expression of PTGES protein] which affects the metabolism of Dinoprostone | CTD | PMID:18479189 |
Gpx2 | Rat | prostaglandin E2 | affects secretion | ISO | Gpx2 (Mus musculus) | 6480464 | GPX2 protein affects the secretion of Dinoprostone | CTD | PMID:18479189 |
Gpx2 | Rat | purine-6-thiol | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Mercaptopurine results in increased expression of GPX2 mRNA | CTD | PMID:18222062 |
Gpx2 | Rat | quercetin | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Quercetin co-treated with Ascorbic Acid] results in increased expression of GPX2 mRNA | CTD | PMID:17639512 |
Gpx2 | Rat | quercetin | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of GPX2 mRNA | CTD | PMID:21632981 and PMID:30152185 |
Gpx2 | Rat | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of GPX2 mRNA | CTD | PMID:18095365 |
Gpx2 | Rat | quercetin | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of GPX2 mRNA | CTD | PMID:17210444 |
Gpx2 | Rat | quercetin | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Quercetin results in decreased expression of GPX2 mRNA | CTD | PMID:16455785 |
Gpx2 | Rat | quercetin 3-O-beta-D-glucofuranoside | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA | CTD | PMID:20033131 |
Gpx2 | Rat | quercetin 3-O-beta-D-glucopyranoside | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GPX2 mRNA | CTD | PMID:20033131 |
Gpx2 | Rat | resveratrol | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | resveratrol results in increased expression of GPX2 mRNA | CTD | PMID:17210444 |
Gpx2 | Rat | resveratrol | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPX2 mRNA | CTD | PMID:23557933 |
Gpx2 | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GPX2 mRNA | CTD | PMID:25905778 |
Gpx2 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | [Resveratrol co-treated with Streptozocin] results in increased expression of GPX2 mRNA and Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of GPX2 mRNA] | CTD | PMID:25905778 and PMID:34067838 |
Gpx2 | Rat | rifampicin | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GPX2 mRNA and [Rifampin co-treated with Cobicistat] results in increased expression of GPX2 mRNA | CTD | PMID:21224054 and PMID:33629115 |
Gpx2 | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Buthionine Sulfoximine results in increased expression of GPX2 mRNA | CTD | PMID:15878706 |
Gpx2 | Rat | salicylic acid | decreases expression | EXP | | 152998891 | Salicylic acid decreases expression of Gpx2 mRNA in proximal and distal colon | RGD | |
Gpx2 | Rat | SB 431542 | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of GPX2 mRNA | CTD | PMID:34480604 |
Gpx2 | Rat | selenium atom | decreases activity | ISO | Gpx2 (Mus musculus) | 6480464 | Selenium deficiency results in decreased activity of GPX2 protein | CTD | PMID:15795427 |
Gpx2 | Rat | selenium atom | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Selenium deficiency results in decreased expression of GPX2 mRNA | CTD | PMID:15795427 |
Gpx2 | Rat | selenium ion | decreases expression | EXP | | 152998882 | Selenium decreases expression of Gpx2 mRNA in the jejunum | RGD | |
Gpx2 | Rat | silicon dioxide | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GPX2 mRNA | CTD | PMID:25895662 |
Gpx2 | Rat | silicon dioxide | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of GPX2 mRNA | CTD | PMID:25351596 |
Gpx2 | Rat | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of GPX2 mRNA | CTD | PMID:32721576 |
Gpx2 | Rat | silver atom | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GPX2 mRNA] | CTD | PMID:22546375 |
Gpx2 | Rat | silver atom | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Silver results in decreased expression of GPX2 mRNA | CTD | PMID:19429238 |
Gpx2 | Rat | silver atom | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Silver results in increased expression of GPX2 mRNA | CTD | PMID:22546375 |
Gpx2 | Rat | silver(0) | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GPX2 mRNA] | CTD | PMID:22546375 |
Gpx2 | Rat | silver(0) | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Silver results in decreased expression of GPX2 mRNA | CTD | PMID:19429238 |
Gpx2 | Rat | silver(0) | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Silver results in increased expression of GPX2 mRNA | CTD | PMID:22546375 |
Gpx2 | Rat | simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of GPX2 mRNA | CTD | PMID:18787804 |
Gpx2 | Rat | sodium arsenate | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | sodium arsenate results in increased expression of GPX2 mRNA | CTD | PMID:12727804 |
Gpx2 | Rat | sodium arsenate | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GPX2 mRNA | CTD | PMID:32525701 |
Gpx2 | Rat | sodium arsenite | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GPX2 mRNA | CTD | PMID:20886546 more ... |
Gpx2 | Rat | sodium arsenite | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in increased expression of GPX2 mRNA | CTD | PMID:32076005 |
Gpx2 | Rat | sodium arsenite | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of GPX2 mRNA | CTD | PMID:29301061 |
Gpx2 | Rat | sodium arsenite | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of GPX2 mRNA | CTD | PMID:21396911 |
Gpx2 | Rat | sodium cholate | multiple interactions | EXP | | 6480464 | [cocoa butter co-treated with Sodium Cholate co-treated with Cholesterol] results in increased expression of GPX2 mRNA | CTD | PMID:26606054 |
Gpx2 | Rat | sodium dichromate | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of GPX2 mRNA | CTD | PMID:22155349 |
Gpx2 | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of GPX2 mRNA | CTD | PMID:22561333 |
Gpx2 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in increased expression of GPX2 mRNA more ... | CTD | PMID:25905778 and PMID:35786680 |
Gpx2 | Rat | sulforaphane | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | sulforaphane results in increased expression of GPX2 mRNA | CTD | PMID:30529165 |
Gpx2 | Rat | Sunset Yellow FCF | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of GPX2 mRNA | CTD | PMID:33819548 |
Gpx2 | Rat | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of GPX2 mRNA | CTD | PMID:26141394 |
Gpx2 | Rat | tert-butyl hydroperoxide | increases reduction | ISO | GPX2 (Homo sapiens) | 6480464 | GPX2 protein results in increased reduction of tert-Butylhydroperoxide | CTD | PMID:8428933 |
Gpx2 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA | CTD | PMID:12419474 |
Gpx2 | Rat | tert-butyl hydroperoxide | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of GPX2 mRNA | CTD | PMID:10806356 and PMID:12414654 |
Gpx2 | Rat | testosterone | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GPX2 mRNA | CTD | PMID:21592394 |
Gpx2 | Rat | testosterone | multiple interactions | EXP | | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPX2 mRNA | CTD | PMID:32741896 |
Gpx2 | Rat | testosterone | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Testosterone results in increased expression of GPX2 mRNA | CTD | PMID:21592394 |
Gpx2 | Rat | Tetrachlorobisphenol A | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | tetrachlorodian results in increased expression of GPX2 mRNA | CTD | PMID:31326446 |
Gpx2 | Rat | tetrachloroethene | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of GPX2 mRNA | CTD | PMID:28973375 |
Gpx2 | Rat | tetrachloromethane | decreases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of GPX2 mRNA | CTD | PMID:23341968 |
Gpx2 | Rat | tetrachloromethane | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of GPX2 mRNA | CTD | PMID:31870920 |
Gpx2 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GPX2 mRNA] | CTD | PMID:31150632 |
Gpx2 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GPX2 mRNA | CTD | PMID:31150632 |
Gpx2 | Rat | tetrachloromethane | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Glycyrrhetinic Acid inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPX2 mRNA] | CTD | PMID:23341968 |
Gpx2 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GPX2 mRNA | CTD | PMID:23411599 and PMID:25242409 |
Gpx2 | Rat | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in increased expression of GPX2 mRNA and [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GPX2 mRNA | CTD | PMID:23830814 |
Gpx2 | Rat | titanium dioxide | affects expression | ISO | Gpx2 (Mus musculus) | 6480464 | titanium dioxide affects the expression of GPX2 mRNA | CTD | PMID:23557971 |
Gpx2 | Rat | toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of GPX2 mRNA | CTD | PMID:18653662 |
Gpx2 | Rat | Tributyltin oxide | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of GPX2 mRNA | CTD | PMID:21601586 |
Gpx2 | Rat | Tributyltin oxide | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of GPX2 mRNA | CTD | PMID:21601586 |
Gpx2 | Rat | triphenyl phosphate | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of GPX2 mRNA | CTD | PMID:37042841 |
Gpx2 | Rat | Triptolide | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | triptolide results in increased expression of GPX2 mRNA | CTD | PMID:31241159 |
Gpx2 | Rat | Triptolide | multiple interactions | ISO | Gpx2 (Mus musculus) | 6480464 | Fenofibrate inhibits the reaction [triptolide results in increased expression of GPX2 mRNA] | CTD | PMID:31241159 |
Gpx2 | Rat | tris(2-butoxyethyl) phosphate | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | tris(2-butoxyethyl) phosphate results in increased expression of GPX2 mRNA | CTD | PMID:25808963 |
Gpx2 | Rat | tris(2-butoxyethyl) phosphate | affects expression | ISO | GPX2 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of GPX2 mRNA | CTD | PMID:29024780 |
Gpx2 | Rat | tris(2-chloroethyl) phosphate | increases expression | ISO | Gpx2 (Mus musculus) | 6480464 | tris(chloroethyl)phosphate results in increased expression of GPX2 mRNA | CTD | PMID:26049154 and PMID:26183808 |
Gpx2 | Rat | troglitazone | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | troglitazone results in increased expression of GPX2 mRNA | CTD | PMID:25572481 |
Gpx2 | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of GPX2 mRNA | CTD | PMID:24136188 |
Gpx2 | Rat | valproic acid | decreases expression | ISO | GPX2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GPX2 mRNA | CTD | PMID:29154799 |
Gpx2 | Rat | valproic acid | decreases methylation | ISO | GPX2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of GPX2 gene | CTD | PMID:29154799 |
Gpx2 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of GPX2 mRNA | CTD | PMID:19015723 |
Gpx2 | Rat | vitamin E | multiple interactions | EXP | | 6480464 | Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA] | CTD | PMID:30003487 |
Gpx2 | Rat | XAV939 | multiple interactions | ISO | GPX2 (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of GPX2 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GPX2 mRNA | CTD | PMID:34480604 |
Gpx2 | Rat | zinc dichloride | increases expression | ISO | GPX2 (Homo sapiens) | 6480464 | zinc chloride results in increased expression of GPX2 mRNA | CTD | PMID:18947441 |